Tate & Lyle PLC Directorate Change
Tate Lyle PLC announces today that Douglas Hurt has been appointed as a Non-Executive Director with effect from 10 March 2010.
Douglas Hurt is Finance Director of IMI plc, the listed international engineering group. Prior to joining IMI plc in 2006, he held a number of financial and operational roles, including US and European senior management positions, at GlaxoSmithKline. He is a member of the Institute of Chartered Accountants.
Sir Peter Gershon, Chairman of Tate Lyle, said "The Board is delighted that Douglas has agreed to join us. His financial and business management experience will be of great benefit to the Board.”
There are no further disclosures to be made in connection with Mr Hurt’s appointment pursuant to paragraph 9.6.13 of the Financial Services Authority’s Listing Rules.
Tate Lyle operates through two global business units, Speciality Food Ingredients and Bulk Ingredients, supported by Innovation and Commercial Development. The Group's strategy is to become the leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving the Bulk Ingredients business for sustained cash generation to fuel this growth.
Speciality Food Ingredients include starch-based speciality ingredients (corn-based speciality starches, sweeteners and fibres), no calorie sweeteners (including SPLENDA® Sucralose) and Food Systems which provides blended ingredient solutions. Bulk Ingredients include corn-based bulk sweeteners, industrial starches and fermentation products (primarily acidulants). The co-products from both divisions are primarily sold as animal feed.
Tate Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2013, Tate Lyle sales totalled £3.3 billion. http://www.tateandlyle.com. SPLENDA® is a trademark of McNeil Nutritionals, LLC
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
